REYON Pharmaceutical Co., Ltd.

₩9,290As of Sun 8 Nov 2026, 12:00 UTC
KRX:102460Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (5.85%)
Div yield —
ROE (15.86%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.41
PE TTM —
TSR TTM (13.90%)
Mkt cap ₩170.4B
ROIC (7.30%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩11,691
25.84%
(85.51%)
Hold 4|10|1|5|5
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
211.82
213.34
231.64
241.28
18.18%
17.86%
16.09%
13.10%
Revenue₩B
12.27
12.60
12.25
11.91
(1.48%)
2.77%
(1.09%)
(4.65%)
Peers (US$125.6M)
Cap (US$)
PE
126.0M
3.284x
121.4M
—
126.2M
—
Capital
TTM
5Y
10Y
Leveragex
0.214
3.611
2.402
EBIT/Intx
0.992
0.164
0.174
Own earn%
0.96
9.56
(1.68)
Sh yield%
38.24
54.36
57.93
Owners
Insiders/Inst%
9.88
74.19
Short interest%
4.58
SBC / revenue%
1.87
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
7–10
$1 testx
—
Incr. ROIC%
4